A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600E/K mutant advanced melanoma. (13th April 2019) - Algazi, Alain Patrick; Rotow, Julia; Posch, Christian; Ortiz‐Urda, Susana; Pelayo, Alyson; Munster, Pamela N.; Daud, Adil